Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 2-{-3,′2-(phenyl)-oxazol-4-ylmethoxyl-cyclohexyl methoxy}-propionic acid derivatives used as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes

2-{-3,′2-(phenyl)-oxazol-4-ylmethoxyl-cyclohexyl methoxy}-propionic acid derivatives used as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes

US Patent 7956077 · Granted Jun 7, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Azetidine compounds as GPR119 modulators for the treatment of diabetes, obesity,2019
Isoindolinone compounds as GPR119 modulators for the treatment of diabetes, obes2018
Substituted indanone compounds as GPR119 modulators for the treatment of diabete2018
Substituted fused heterocycles as GPR119 modulators for the treatment of diabete2017
Annelated N-heterocyclic sulfonamides with oxadiazolone headgroup, processes for2015
Annelated N-heterocyclic sulfonamides with oxadiazolone headgroup, processes for2015
Annelated N-heterocyclic sulfonamides with oxadiazolone headgroup, processes for2015
Spirocyclically substituted 1,3-propane dioxide derivatives, processes for prepa2014
Pyrrolidinone derivatives as GPR119 modulators for the treatment of diabetes, ob2014
Sulfonamides with heterocycle and oxadiazolone headgroup, processes for their pr2014
Sulfonamides with heterocycle and oxadiazolone headgroup, processes for their pr2014
(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparatio2014